BioNTech SE: xbrl:CashFlowsFromUsedInOperatingActivities
| Value | {"unit": "EUR", "value": -13474000} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | superseded |
| Entity | BioNTech SE |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/8c8943ef-8a9d-4f12-8199-530d7a17bc18
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-016723Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/8c8943ef-8a9d-4f12-8199-530d7a17bc18
History
- no predecessors — first report